跳至主要内容
临床试验/ACTRN12624000803594
ACTRN12624000803594尚未招募4 期

Profiling the effects of oestrogens, progestogens and allopregnanolone on the brain during neurosteroid withdrawal: toward treating catamenial epilepsy

The University of Auckland0 个研究点目标入组 150 人开始时间: 2024年6月28日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 40 Years(—)
性别
Female

入选标准

  • 1Participants must be willing and able to give informed consent for participation in the study.
  • 2Female (sex presumed female at birth) aged 18-40 years inclusive
  • 3BMI 18-35
  • 4In the Investigators’ opinion, is able and willing to comply with all study requirements
  • 5Must have been stable either on or off neuroactive medications for around 2 months

排除标准

  • 1Are older than 40, or under 18 years of age
  • 2Are currently pregnant, lactating or intending to become pregnant
  • 3Current use of any hormonal medication that suppresses the menstrual cycle (hormonal intrauterine implants such as Mirena are acceptable if the person is ovulating)
  • 4Have ever undergone gender affirming surgical or recent hormone treatment procedures
  • 5Have polycystic ovary syndrome or periods so irregular that they more often than not 1 week longer or shorter than their average
  • 6Have premenstrual dysphoric disorder (menstrual cycle related depressive episodes) or menstrual migraine
  • 7Have been regularly using any other medication the research team considers may be a problem for the study measures
  • 8Any planned changes to neuroactive medication in timeframe of study participation
  • 9Inability to speak or read English
  • 10Any other condition judged by the study team as likely to impact on the ability of the participant to complete the study
  • 11In the overseeing clinicians opinion is contraindicated to receive the intervention

研究者

相似试验

Profiling how female sex steroids affect the brain... | 临床试验